Genome-Wide Association Study of Susceptibility to Idiopathic Pulmonary Fibrosis

dc.contributorHáskóli Íslandsen_US
dc.contributorUniversity of Icelanden_US
dc.contributor.authorAllen, Richard J.
dc.contributor.authorGuillen-Guio, Beatriz
dc.contributor.authorOldham, Justin M.
dc.contributor.authorMa, Shwu-Fan
dc.contributor.authorDressen, Amy
dc.contributor.authorPaynton, Megan L.
dc.contributor.authorKraven, Luke M.
dc.contributor.authorObeidat, Ma'en
dc.contributor.authorLi, Xuan
dc.contributor.authorNg, Michael
dc.contributor.authorBraybrooke, Rebecca
dc.contributor.authorMolina-Molina, Maria
dc.contributor.authorHobbs, Brian D.
dc.contributor.authorPutman, Rachel K.
dc.contributor.authorSakornsakolpat, Phuwanat
dc.contributor.authorBooth, Helen L.
dc.contributor.authorFahy, William A.
dc.contributor.authorHart, Simon P.
dc.contributor.authorHill, Mike R.
dc.contributor.authorHirani, Nik
dc.contributor.authorHubbard, Richard B.
dc.contributor.authorMcAnulty, Robin J.
dc.contributor.authorMillar, Ann B.
dc.contributor.authorNavaratnam, Vidyia
dc.contributor.authorOballa, Eunice
dc.contributor.authorParfrey, Helen
dc.contributor.authorSaini, Gauri
dc.contributor.authorWhyte, Moira K. B.
dc.contributor.authorZhang, Yingze
dc.contributor.authorKaminski, Naftali
dc.contributor.authorAdegunsoye, Ayodeji
dc.contributor.authorStrek, Mary E.
dc.contributor.authorNeighbors, Margaret
dc.contributor.authorSheng, Xuting R.
dc.contributor.authorGuðmundsson, Gunnar
dc.contributor.authorGudnason, Vilmundur
dc.contributor.authorHatabu, Hiroto
dc.contributor.authorLederer, David J.
dc.contributor.authorManichaikul, Ani
dc.contributor.authorNewell, John D.
dc.contributor.authorO’Connor, George T.
dc.contributor.authorOrtega, Victor E.
dc.contributor.authorXu, Hanfei
dc.contributor.authorFingerlin, Tasha E.
dc.contributor.authorBossé, Yohan
dc.contributor.authorHao, Ke
dc.contributor.authorJoubert, Philippe
dc.contributor.authorNickle, David C.
dc.contributor.authorSin, Don D.
dc.contributor.authorTimens, Wim
dc.contributor.authorFurniss, Dominic
dc.contributor.authorMorris, Andrew P.
dc.contributor.authorZondervan, Krina T.
dc.contributor.authorHall, Ian P.
dc.contributor.authorSayers, Ian
dc.contributor.authorTobin, Martin D.
dc.contributor.authorMaher, Toby M.
dc.contributor.authorCho, Michael H.
dc.contributor.authorHunninghake, Gary M.
dc.contributor.authorSchwartz, David A.
dc.contributor.authorYaspan, Brian L.
dc.contributor.authorMolyneaux, Philip L.
dc.contributor.authorFlores, Carlos
dc.contributor.authorNoth, Imre
dc.contributor.authorJenkins, R. Gisli
dc.contributor.authorWain, Louise V.
dc.contributor.departmentLæknadeild (HÍ)en_US
dc.contributor.departmentFaculty of Medicine (UI)en_US
dc.contributor.schoolHeilbrigðisvísindasvið (HÍ)en_US
dc.contributor.schoolSchool of Health Sciences (UI)en_US
dc.date.accessioned2021-01-28T11:33:34Z
dc.date.available2021-01-28T11:33:34Z
dc.date.issued2020-03-01
dc.descriptionPublisher's version (útgefin grein)en_US
dc.description.abstractRationale: Idiopathic pulmonary fibrosis (IPF) is a complex lung disease characterized by scarring of the lung that is believed to result from an atypical response to injury of the epithelium. Genome-wide association studies have reported signals of association implicating multiple pathways including host defense, telomere maintenance, signaling, and cell-cell adhesion. Objectives: To improve our understanding of factors that increase IPF susceptibility by identifying previously unreported genetic associations. Methods: We conducted genome-wide analyses across three independent studies and meta-analyzed these results to generate the largest genome-wide association study of IPF to date (2,668 IPF cases and 8,591 controls). We performed replication in two independent studies (1,456 IPF cases and 11,874 controls) and functional analyses (including statistical fine-mapping, investigations into gene expression, and testing for enrichment of IPF susceptibility signals in regulatory regions) to determine putatively causal genes. Polygenic risk scores were used to assess the collective effect of variants not reported as associated with IPF. Measurements and Main Results: We identified and replicated threenewgenome-wide significant (P<5×10-8) signals of association with IPF susceptibility (associated with altered gene expression of KIF15, MAD1L1, and DEPTOR) and confirmed associations at 11 previously reported loci. Polygenic risk score analyses showed that the combined effect of many thousands of as yet unreported IPF susceptibility variants contribute to IPF susceptibility. Conclusions: The observation that decreased DEPTOR expression associates with increased susceptibility to IPF supports recent studies demonstrating the importance of mTOR signaling in lung fibrosis. New signals of association implicating KIF15 and MAD1L1 suggest a possible role of mitotic spindle-assembly genes in IPF susceptibility.en_US
dc.description.sponsorshipR.J.A. is an Action for Pulmonary Fibrosis Research Fellow. L.V.W. holds a GSK/British Lung Foundation Chair in Respiratory Research. R.G.J. is supported by a National Institute for Health Research (NIHR) Research Professorship (NIHR reference RP-2017-08-ST2-014). I.N. is supported by the NHLBI (R01HL130796). B.G.-G. is funded by Agencia Canaria de Investigación, Innovación y Sociedad de la Información (TESIS2015010057) cofunded by European Social Fund. J.M.O. is supported by the NHLBI (K23HL138190). C.F. is supported by the Spanish Ministry of Science, Innovation and Universities (grant RTC-2017-6471-1; Ministerio de Ciencia e Innovacion/Agencia Estatal de Investigación/Fondo Europeo de Desarrollo Regional, Unión Europea) cofinanced by the European Regional Development Funds “A way of making Europe” from the European Union and by agreement OA17/008 with Instituto Tecnológico y de Energías Renovables to strengthen scientific and technological education, training, research, development and innovation in Genomics, Personalized Medicine and Biotechnology. The Spain Biobank array genotyping service was performed at CEGEN-PRB3-ISCIII, which is supported by PT17/0019, of the PE I+D+i 2013–2016, funded by Instituto de Salud Carlos III, and cofinanced by the European Regional Development Funds. P.L.M. is an Action for Pulmonary Fibrosis Research Fellow. M.O. is a fellow of the Parker B. Francis Foundation and a Scholar of the Michael Smith Foundation for Health Research. B.D.H. is supported by NIH K08 HL136928, Parker B. Francis Research Opportunity Award. M.H.C. and G.M.H. are supported by NHLBI grants R01HL113264 (M.H.C.), R01HL137927 (M.H.C.), R01HL135142 (M.H.C. and G.M.H.), R01111024 (G.M.H.), and R01130974 (G.M.H.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The funding body has no role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript. T.M.M. is supported by an NIHR Clinician Scientist Fellowship (NIHR Ref: CS-2013-13-017) and a British Lung Foundation Chair in Respiratory Research (C17-3). M.D.T. is supported by a Wellcome Trust Investigator Award (WT202849/Z/16/Z). The research was partially supported by the NIHR Leicester Biomedical Research Centre; the views expressed are those of the author(s) and not necessarily those of the National Health Service (NHS), the NIHR, or the Department of Health. I.P.H. was partially supported by the NIHR Nottingham Biomedical Research Centre; the views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR, or the Department of Health. I.S. is supported by Medical Research Council (G1000861) and Asthma UK (AUK-PG-2013-188). D.F. was supported by an Intermediate Fellowship from the Wellcome Trust (097152/Z/11/Z). This work was partially supported by the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre. V.N. is funded by an NIHR Clinical Lectureship. G.G. is supported by project grant 141513-051 from the Icelandic Research Fund and Landspitali Scientific Fund A-2016-023, A-2017-029, and A-2018-025. D.J.L. and A.M. are supported by Multi-Ethnic Study of Atherosclerosis (MESA) and the MESA SNP Health Association Resource (SHARe) project are conducted and supported by the NHLBI in collaboration with MESA investigators. Support for MESA is provided by contracts HHSN268201500003I, N01-HC-95159, N01-HC-95160, N01-HC-95161, N01-HC-95162, N01-HC-95163, N01-HC-95164, N01-HC-95165, N01-HC-95166, N01-HC-95167, N01-HC-95168, N01-HC-95169, UL1-TR-000040, UL1-TR-001079, UL1-TR-001420, UL1-TR-001881, and DK063491. Funding for SHARe genotyping was provided by NHLBI Contract N02-HL-64278. Genotyping was performed at Affymetrix (Santa Clara, California) and the Broad Institute of Harvard and Massachusetts Institute of Technology (Boston, Massachusetts) using the Affymetrix Genome-Wide Human SNP Array 6.0. This work was supported by NIH grants R01 HL131565 (A.M.), R01 HL103676 (D.J.L.), and R01 HL137234 (D.J.L.).en_US
dc.description.versionPeer Revieweden_US
dc.format.extent564-574en_US
dc.identifier.citationAllen, R. J., et al. (2019). "Genome-Wide Association Study of Susceptibility to Idiopathic Pulmonary Fibrosis." American Journal of Respiratory and Critical Care Medicine 201(5): 564-574.en_US
dc.identifier.doi10.1164/rccm.201905-1017OC
dc.identifier.issn1073-449X
dc.identifier.issn1535-4970 (eISSN)
dc.identifier.journalAmerican Journal of Respiratory and Critical Care Medicineen_US
dc.identifier.urihttps://hdl.handle.net/20.500.11815/2428
dc.language.isoenen_US
dc.publisherAmerican Thoracic Societyen_US
dc.relation.ispartofseriesAmerican Journal of Respiratory and Critical Care Medicine;201(5)
dc.relation.urlhttps://www.atsjournals.org/doi/pdf/10.1164/rccm.201905-1017OCen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectDEPTORen_US
dc.subjectEpidemiologyen_US
dc.subjectGeneticsen_US
dc.subjectKIF15en_US
dc.subjectMAD1L1en_US
dc.subjectErfðafræðien_US
dc.subjectGenarannsókniren_US
dc.subjectLungnasjúkdómaren_US
dc.titleGenome-Wide Association Study of Susceptibility to Idiopathic Pulmonary Fibrosisen_US
dc.typeinfo:eu-repo/semantics/articleen_US
dcterms.licenseThis article is open access and distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/ licenses/by/4.0/).en_US

Skrár

Original bundle

Niðurstöður 1 - 1 af 1
Nafn:
s41380-019-0358-8.pdf
Stærð:
311.72 KB
Snið:
Adobe Portable Document Format
Description:
Publisher´s version

Undirflokkur